Authors

• Chisom Kanu (ORCID: https://orcid.org/0000-0002-2621-8652)
• Barry A. Borlaug (ORCID: https://orcid.org/0000-0001-9375-0596)
• Christopher M. Kramer (ORCID: https://orcid.org/0000-0003-2057-7731)
• Milton Packer (ORCID: https://orcid.org/0000-0003-1828-2387)
• Michael R. Zile (ORCID: https://orcid.org/0000-0001-7076-221X)
• Sheldon E. Litwin (ORCID: https://orcid.org/0000-0002-5887-8161)
• Venu Menon (ORCID: https://orcid.org/0000-0003-4410-2677)
• Karla Hurt
• Govinda J. Weerakkody (ORCID: https://orcid.org/0000-0003-0595-5554)
• Seth J. Baum (ORCID: https://orcid.org/0000-0003-1202-8126)
• Masahiro Murakami
• Yang Ou (ORCID: https://orcid.org/0009-0004-5020-7912)

Institutions

• Cleveland Clinic (US)
• Mayo Clinic (US)
• Medical University of South Carolina (US)
• Eli Lilly (United States) (US)
• University of Virginia Health System (US)
• Cleveland Foundation (US)
• Baylor University Medical Center (US)
• Boca Raton Regional Hospital (US)
• NIHR Imperial Biomedical Research Centre (GB)
• Mayo Clinic in Arizona (US)
• Imperial College London (GB)

Publication Details

Journal

Circulation

Published

2024-11-18

DOI

https://doi.org/10.1161/circulationaha.124.072679

Citations

42

Primary Topic

Diabetes Treatment and Management

Type

article

Field-Weighted Citation Impact

15.02

Funders

• Eli Lilly and Company